Kim JY - Search Results

1

Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer.

Kim HS, Kim JY, Lee YJ, Kim SH, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT. Kim HS, et al. Among authors: kim jy, kim sw, kim sh, kim s, kim yt. Gynecol Oncol. 2018 Dec;151(3):414-421. doi: 10.1016/j.ygyno.2018.08.023. Epub 2018 Oct 9. Gynecol Oncol. 2018. PMID: 30314669

2

Clinical outcomes of advanced-stage glassy cell carcinoma of the uterine cervix: a need for reappraisal.

Yoon N, Kim JY, Kim HS. Yoon N, et al. Among authors: kim jy, kim hs. Oncotarget. 2016 Nov 29;7(48):78448-78454. doi: 10.18632/oncotarget.12905. Oncotarget. 2016. PMID: 27793022 Free PMC article.

3

Stromal p16 expression is significantly increased in endometrial carcinoma.

Yoon G, Koh CW, Yoon N, Kim JY, Kim HS. Yoon G, et al. Among authors: kim jy, kim hs. Oncotarget. 2017 Jan 17;8(3):4826-4836. doi: 10.18632/oncotarget.13594. Oncotarget. 2017. PMID: 27902476 Free PMC article.

4

Clinicopathological Characteristics of Mitotically-active Cellular Fibroma of the Ovary: A Single-institutional Experience.

Kim JY, Na K, Kim HS. Kim JY, et al. Among authors: kim hs. Anticancer Res. 2017 May;37(5):2557-2564. doi: 10.21873/anticanres.11599. Anticancer Res. 2017. PMID: 28476827

5

Clinicopathological Characteristics of Metaplastic Papillary Tumor of the Fallopian Tube.

Jang MI, Sung JY, Kim JY, Kim HS. Jang MI, et al. Among authors: kim jy, kim hs. Anticancer Res. 2017 Jul;37(7):3693-3701. doi: 10.21873/anticanres.11741. Anticancer Res. 2017. PMID: 28668862

6

B-cell translocation gene 1 is downregulated by promoter methylation in ovarian carcinoma.

Kim JY, Do SI, Bae GE, Kim HS. Kim JY, et al. Among authors: kim hs. J Cancer. 2017 Aug 22;8(14):2669-2675. doi: 10.7150/jca.21037. eCollection 2017. J Cancer. 2017. PMID: 28928854 Free PMC article.

7

Down-regulation of B-Cell Translocation Gene 1 by Promoter Methylation in Colorectal Carcinoma.

Jung YY, Sung JY, Kim JY, Kim HS. Jung YY, et al. Among authors: kim jy, kim hs. Anticancer Res. 2018 Feb;38(2):691-697. doi: 10.21873/anticanres.12274. Anticancer Res. 2018. PMID: 29374692

8

Promoter Methylation Down-regulates Osteoprotegerin Expression in Ovarian Carcinoma.

Kim JY, Kim SH, Kim HS. Kim JY, et al. Among authors: kim sh, kim hs. Anticancer Res. 2019 May;39(5):2361-2367. doi: 10.21873/anticanres.13353. Anticancer Res. 2019. PMID: 31092428

9

Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression.

Bahar E, Kim JY, Kim HS, Yoon H. Bahar E, et al. Among authors: kim jy, kim hs. Int J Mol Sci. 2020 Oct 15;21(20):7613. doi: 10.3390/ijms21207613. Int J Mol Sci. 2020. PMID: 33076245 Free PMC article.

10

Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer.

Chang JS, Kim N, Kim JY, Do SI, Cho Y, Kim HS, Kim YB. Chang JS, et al. Among authors: kim jy, kim n, kim yb, kim hs. J Gynecol Oncol. 2020 Nov;31(6):e78. doi: 10.3802/jgo.2020.31.e78. J Gynecol Oncol. 2020. PMID: 33078588 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,732 results

Search Page

Filters